Certified by Founder Lodge
TRexBio
United States - South San Francisco, California
START UP
1 Disclosed Funding Rounds $84,000,000
0 Participating Investments
-
Founded date
2018
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
TRexBio is a discovery stage biotechnology company leveraging cutting edge computational biology tools, a focus on human tissue, and expertise in immunobiology to develop revolutionary therap
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| November, 14 ,2024 | Series B | $84,000,000 |
Johnson & Johnson
Eli Lilly and Company
Polaris Partners
SV Health Investors
Pfizer
Agent Capital
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Alchemyca Biotech | $2,500,000 | (Nov 22, 2024)
Shinami | $5,645,000 | (Nov 22, 2024)
Iontra Inc | $45,000,000 | (Nov 22, 2024)
Clean Skin Club | $32,000,000 | (Nov 22, 2024)
Lighthouse (UK) | $370,000,000 | (Nov 22, 2024)
